GlassScriptPhysician profile
Dylan R Wells
NPI 1487611950
$3,961.90
in general payments reported to CMS, 2019-2025
44 companies · $263 in 2025
The $263 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $889 · 2020: $380 · 2021: $930 · 2022: $593 · 2023: $579 · 2024: $328 · 2025: $263.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,170.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,169.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $701.92 | 2019-2024 | Orilissa, Lo Loestrin Fe, Oriahnn |
| Bayer Healthcare Pharmaceuticals INC. | $292.39 | 2019-2025 | |
| Pfizer INC. | $252.47 | 2019-2024 | |
| Astellas Pharma US INC | $202.40 | 2019-2025 | Veozah, Myrbetriq |
| Novo Nordisk INC | $170.73 | 2020-2023 | Wegovy |
| Hologic Sales and Service, LLC | $155.50 | 2019-2025 | Coolseal Generator, Aptima |
| Avion Pharmaceuticals | $155.25 | 2020-2023 | Balcoltra |
| Mylan Pharmaceuticals INC. | $144.03 | 2020-2022 | |
| Allergan, INC. | $141.84 | 2019 | |
| Coopersurgical, INC. | $131.36 | 2020-2025 | Mara Console, Paragard T 380a, Paragard T 380a |
| Takeda Pharmaceuticals U.S.A., INC. | $130.42 | 2019-2023 | Trintellix |
| Mayne Pharma Commercial LLC | $122.17 | 2023-2025 | |
| Currax Pharmaceuticals LLC | $93.03 | 2019-2022 | |
| Davol INC. | $87.86 | 2021 | |
| Therapeuticsmd, INC. | $82.59 | 2019-2022 |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dylan Wells listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.